Theophylline Tablet, Extended Release
Product Images NDC 27241-272

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 27241-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

450mg (Theophylline 450mg)

Theophylline Extended-Release Tablets 450 mg film-coated tablets. The label shows a 100-tablet package marketed by Ajanta Pharma USA Inc., with storage instructions and child-resistant packaging information. The label includes NDC 27241-273-01 and indicates the product is made in India.*

FDA Label Image

Theophylline (Theophylline Structure)

Chemical structure diagram of the active ingredient theophylline, showing its molecular arrangement and key functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.